Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minetaro Arita

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
The Journal of Infectious Diseases|January 6, 2018
Intestinal Immune Responses to Type 2 Oral Polio Vaccine (OPV) Challenge in Infants Previously Immunized With Bivalent OPV and Either High-Dose or Standard Inactivated Polio VaccineElizabeth B Brickley, Carolyn B Strauch, Wendy F Wieland-Alter, et al.
The Journal of Infectious Diseases|January 25, 2014
Intestinal immunity is a determinant of clearance of poliovirus after oral vaccinationPeter F Wright, Wendy Wieland-Alter, Natalia A Ilyushina, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 4, 2025
Intestinal mucosal immune responses to novel oral poliovirus vaccine type 2 in healthy newbornsAudrey Godin, Elizabeth B Brickley, Ruth I Connor, et al.
BMJ Global Health|September 24, 2019
Intestinal antibody responses to a live oral poliovirus vaccine challenge among adults previously immunized with inactivated polio vaccine in SwedenElizabeth B Brickley, Ruth I Connor, Wendy F Wieland-Alter, et al.
The Lancet. Microbe|May 3, 2025
Intestinal mucosal immune responses induced by novel oral poliovirus vaccine type 2 and Sabin monovalent oral poliovirus vaccine type 2: an analysis of data from four clinical trialsAudrey Godin, Elizabeth B Brickley, Ruth I Connor, et al.
Journal of Virology|August 5, 2016
Fungus-Derived Neoechinulin B as a Novel Antagonist of Liver X Receptor, Identified by Chemical Genetics Using a Hepatitis C Virus Cell Culture SystemSyo Nakajima, Koichi Watashi, Hirofumi Ohashi, et al.
The Journal of Infectious Diseases|May 29, 2024
Nasal and Pharyngeal Mucosal Immunity to Poliovirus in Children Following Routine Immunization With Inactivated Polio Vaccine in the United StatesAudrey Godin, Ruth I Connor, Hanna N Degefu, et al.
Cell Reports|February 3, 2015
Itraconazole inhibits enterovirus replication by targeting the oxysterol-binding proteinJeroen R P M Strating, Lonneke van der Linden, Lucian Albulescu, et al.
Vaccine|March 26, 2022
Concurrent outbreaks of circulating vaccine-derived poliovirus types 1 and 2 affecting the Republic of the Philippines and Malaysia, 2019-2021Cynthia J Snider, Liliane Boualam, Graham Tallis, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
The Journal of Infectious Diseases|January 6, 2018
Intestinal Immune Responses to Type 2 Oral Polio Vaccine (OPV) Challenge in Infants Previously Immunized With Bivalent OPV and Either High-Dose or Standard Inactivated Polio VaccineElizabeth B Brickley, Carolyn B Strauch, Wendy F Wieland-Alter, et al.
The Journal of Infectious Diseases|January 25, 2014
Intestinal immunity is a determinant of clearance of poliovirus after oral vaccinationPeter F Wright, Wendy Wieland-Alter, Natalia A Ilyushina, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 4, 2025
Intestinal mucosal immune responses to novel oral poliovirus vaccine type 2 in healthy newbornsAudrey Godin, Elizabeth B Brickley, Ruth I Connor, et al.
BMJ Global Health|September 24, 2019
Intestinal antibody responses to a live oral poliovirus vaccine challenge among adults previously immunized with inactivated polio vaccine in SwedenElizabeth B Brickley, Ruth I Connor, Wendy F Wieland-Alter, et al.
The Lancet. Microbe|May 3, 2025
Intestinal mucosal immune responses induced by novel oral poliovirus vaccine type 2 and Sabin monovalent oral poliovirus vaccine type 2: an analysis of data from four clinical trialsAudrey Godin, Elizabeth B Brickley, Ruth I Connor, et al.
Journal of Virology|August 5, 2016
Fungus-Derived Neoechinulin B as a Novel Antagonist of Liver X Receptor, Identified by Chemical Genetics Using a Hepatitis C Virus Cell Culture SystemSyo Nakajima, Koichi Watashi, Hirofumi Ohashi, et al.
The Journal of Infectious Diseases|May 29, 2024
Nasal and Pharyngeal Mucosal Immunity to Poliovirus in Children Following Routine Immunization With Inactivated Polio Vaccine in the United StatesAudrey Godin, Ruth I Connor, Hanna N Degefu, et al.
Cell Reports|February 3, 2015
Itraconazole inhibits enterovirus replication by targeting the oxysterol-binding proteinJeroen R P M Strating, Lonneke van der Linden, Lucian Albulescu, et al.
Vaccine|March 26, 2022
Concurrent outbreaks of circulating vaccine-derived poliovirus types 1 and 2 affecting the Republic of the Philippines and Malaysia, 2019-2021Cynthia J Snider, Liliane Boualam, Graham Tallis, et al.
Pageof 6